Chloroethylclonidine

Chloroethylclonidine
Clinical data
ATC code	none;
Identifiers
	IUPAC name N-[2,6-Dichloro-4-[(2-chloroethyl-methylamino)methyl]phenyl]-4,5-dihydro-1H-imidazol-2-amine;
CAS Number	98086-36-3 ;
PubChem CID	104973;
ChemSpider	94725 ;
UNII	3X825O680H;
CompTox Dashboard (EPA)	DTXSID40913463 ;
ECHA InfoCard	100.163.420
Chemical and physical data
Formula	C13H17Cl3N4
Molar mass	335.66 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES ClCCN(C)Cc2cc(Cl)c(N/C1=N/CCN1)c(Cl)c2;
	InChI InChI=1S/C13H17Cl3N4/c1-20(5-2-14)8-9-6-10(15)12(11(16)7-9)19-13-17-3-4-18-13/h6-7H,2-5,8H2,1H3,(H2,17,18,19) ; Key:XFDVJGKSQRUEEM-UHFFFAOYSA-N ;
	(what is this?) (verify)

Chloroethylclonidine is an irreversible agonist for adrenergic receptors, in particular alpha1B, D, C and alpha2A/D-subtypes.^[1]

References

^ Docherty JR, O'Rourke M (February 1997). "The alpha-adrenoceptor-mediated actions of chloroethylclonidine". General Pharmacology. 28 (2): 197–201. doi:10.1016/s0306-3623(96)00187-5. PMID 9013194.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.